With reference to its letter dated July 30, 2025 informing that Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company, entered into a definitive agreement with LANNETT SELLER HOLDCO, INC under which Aurobindo Pharma USA Inc will acquire 100% of membership interest in Lannett Company LLC from LANNETT SELLER HOLDCO, INC. In this regard, Aurobindo Pharma has informed that it enclosed that the necessary approval from US Federal Trade Commission (FTC) for the acquisition of the Lannett business has been obtained today. The company anticipate that the transaction will close before the end of this month and will keep the exchanges informed if any future developments in this matter.
The above information is a part of company’s filings submitted to BSE.
